TipRanks
Go Ultimate55% OFF

Iofina plc (IOF) AI Stock Analysis

GB:IOF

Iofina plc

(LSE:IOF)

Select Model
Rating:74Outperform
Price Target:GBX 57.00â–²(10.68% Upside)
Action:reiterated
Date:10/17/26

The score is driven primarily by solid fundamentals (growth, profitability, and a low-leverage balance sheet), supported by a strongly positive earnings call highlighting production growth and capacity expansion. Offsetting factors are weaker near-term technicals (price below key moving averages with subdued RSI) and uneven free-cash-flow conversion, while valuation appears reasonable on a mid-teens P/E.

Positive Factors
Production ExpansionProduction growth and a defined expansion pipeline can increase Iofina’s scale and market presence over the next several quarters. The 29% first-half production increase, IO#12 ramp and planned IO#13/IO#14 additions provide tangible capacity drivers beyond existing operations.
Negative Factors
Volatile Free Cash FlowHealthy operating cash flow has not translated consistently into free cash flow, which was about $2.5m in 2025 and volatile year to year. This can constrain self-funded expansion and makes reported earnings less reliable as a measure of cash available for investment.

Iofina plc (IOF) vs. iShares MSCI United Kingdom ETF (EWC)

-25%0%25%50%75%100%125%150%175%GB:IOF+128.89%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
GBP 98.81M
Dividend Yield
―
Average Volume (3M)
328.09K
Price to Earnings (P/E)
15.0
Beta (1Y)
0.10
Revenue Growth
14.87%
EPS Growth
77.32%
Country
UK
Employees
126
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Iofina plc Business Overview & Revenue Model

Company Description

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offer...

How the Company Makes Money

Iofina makes money primarily by producing and selling iodine and iodine derivatives. Its core revenue stream comes from the sale of crystalline iodine produced from iodine-rich brine streams using its extraction processes, with sales typically linked...

Iofina plc Earnings Call Summary

Earnings Call Date:Sep 20, 2026(Q2-2026)|% Change Since:0.98%|Next Earnings Date:May 05, 2027
Earnings Call SentimentPositive

The call was strongly positive, with record first-half operating and financial performance, a 29% increase in iodine production, sharply improved gross profit and EBITDA, positive cash generation, strong customer demand, and multiple plants advancing toward the pathway to 2,000 metric tons. The main challenges were rising chemical costs, regulatory delays at IO#12, a deferred delivery, limited specificity on IO#13 and IO#14 tonnage, and the continued prioritization of reinvestment over dividends. Highlights significantly outweighed the lowlights.

Positive Updates

Iodine Production Increased 29%
First-half 2026 iodine production increased by 29% versus the first half of 2025, representing an additional 88 metric tons. IO#11 contributed 50 metric tons of the increase, while another plant contributed an additional 18 metric tons due to new wells and fresh drilling by an oil and gas partner.

Negative Updates

Chemical Costs Began Creeping Higher
Although chemical costs improved in the first half, management reported some cost creep entering the second half, mainly due to higher raw-material costs influenced by fuel-price increases and supply shortages involving materials manufactured in the Middle East.

Company Guidance

IO#12 is expected to be moving water through the facility in the next few weeks and ramp up in production shortly thereafter, with capacity for about 50,000 bpd of water and plant capital costs expected to come in right around $8.8 million; IO#11 is expected to increase from a 100 metric ton plant to somewhere between 145 and 160 metric tons of production; IO#13 and IO#14 are anticipated to come online in the first half of next year, with total volume likely to be higher than the average amounts of plants in Oklahoma, which are somewhere between 100 and 150 metric ton of plants on average; production capacity is expected to exceed 1,000 metric tons once IO#12 comes online, with a pathway to 2,000 metric tons; the company is on track to meet market expectations in fiscal year 2026, expects increases in iodine production all the time, and said profitability should increase at the same time as long as it can control costs and the iodine market continues to expand; it has sales in hand for all of the projected production planned to be sold into the open market throughout the rest of the year and expects to start selling iodine or taking purchase orders for iodine into 2027 shortly.

Iofina plc Financial Statement Overview

Summary

Strong revenue growth into 2025 and solid profitability, supported by a conservatively financed balance sheet with low leverage and expanding equity. The main offset is cash conversion: operating cash flow is healthy, but free cash flow has been thin and volatile, alongside year-to-year margin variability.

Income Statement

78Positive

Balance Sheet

86Very Positive

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue68.25M67.91M54.47M50.04M42.20M39.04M
Gross Profit18.45M15.22M13.24M15.65M15.83M10.73M
EBITDA15.09M12.06M7.65M10.74M12.18M7.22M
Net Income8.81M8.03M2.92M6.56M7.87M9.19M
Balance Sheet
Total Assets84.06M79.23M63.78M60.52M52.71M44.45M
Cash, Cash Equivalents and Short-Term Investments12.98M11.74M6.86M6.52M5.93M5.26M
Total Debt6.43M6.66M4.26M5.84M7.20M8.68M
Total Liabilities24.57M23.53M15.99M15.77M14.73M14.48M
Stockholders Equity59.49M55.70M47.79M44.75M37.97M29.96M
Cash Flow
Free Cash Flow8.33M2.54M2.02M2.34M2.46M6.41M
Operating Cash Flow16.91M11.10M11.53M8.57M5.55M7.89M
Investing Cash Flow-8.59M-8.56M-9.34M-6.10M-3.07M-1.47M
Financing Cash Flow-1.82M2.43M-1.85M-1.88M-1.81M-4.64M

Iofina plc Technical Analysis

Technical Analysis SentimentNeutral
Last Price51.50

Price Trends

50DMA52.07Negative
100DMA53.00Negative
200DMA42.63Positive

Market Momentum

MACD-0.55Positive
RSI48.60Neutral
STOCH65.97Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IOF, the sentiment is Neutral. The current price of 51.50 is below the 20-day moving average (MA) of 52.40, below the 50-day MA of 52.07, and above the 200-day MA of 42.63, indicating a neutral trend. The MACD of -0.55 indicates Positive momentum. The RSI at 48.60 is Neutral, neither overbought nor oversold. The STOCH value of 65.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:IOF.

Iofina plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

GB:IOF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:IOFGB:IOF74OutperformGBP 98.81M15.0315.30%―14.87%77.32%
GB:ELMGB:ELM73OutperformGBP 1.06B19.3611.29%1.78%-11.73%―
GB:CRDAGB:CRDA66NeutralGBP 5.09B64.433.65%3.05%3.36%-43.08%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
GB:SYNTGB:SYNT57NeutralGBP 181.98M-1.52-13.27%―-4.98%-43.98%
GB:JMATGB:JMAT51NeutralGBP 2.97B-41.89-4.66%4.49%7.70%-128.58%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%100%150%GB:IOFGB:CRDAGB:ELMGB:JMATGB:SYNTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:IOF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:IOFIofina plc51.5028.50123.91%
GB:CRDACroda International3644.00919.5333.75%
GB:ELMElementis plc187.2025.8416.01%
GB:JMATJohnson Matthey (Uk)2388.00270.5412.78%
GB:SYNTSynthomer plc111.0058.70112.24%

Iofina plc Corporate Events

Business Operations and StrategyFinancial Disclosures

Iofina Pushes Ahead With Iodine Capacity Expansion Despite Q3 Production Dip

Positive
Oct 16, 2026

Iofina reported further progress on its production expansion in Q3 2026, completing an additional brine supply pipeline at its IO#11 plant, preparing IO#12 to start producing, and signing agreements to begin construction of new IO#13 and IO#14 facili...

Business Operations and Strategy

Iofina Commissions First Commercial Iodine Plant in Permian Basin

Positive
Oct 16, 2026

Iofina plc has commissioned its new IO#12 IOsorb® iodine plant, the company’s largest facility to date and the first commercial-scale iodine production site in the Permian Basin. The plant is currently undergoing hydrotesting, with brine w...

Business Operations and StrategyFinancial Disclosures

Iofina Doubles EBITDA as Iodine Output Surges and Expansion Accelerates

Positive
Sep 21, 2026

Iofina reported record first-half 2026 revenue of $31.3 million, up 7% year-on-year, with cost of sales down 8%, lifting gross profit 62% to $10.2 million. Adjusted EBITDA more than doubled to $6.6 million, operating profit surged 178% to $4.9 millio...

Business Operations and Strategy

Iofina to Build Two New IOsorb Plants in Oklahoma to Boost Iodine Output

Positive
Sep 14, 2026

Iofina plc has signed agreements with an existing brine supply partner to build two new IOsorb plants, IO#13 and IO#14, in its core central Oklahoma area, marking its largest project in this region to date. Construction on the plants will proceed con...

Business Operations and Strategy

Iofina boosts IO#11 output and advances largest iodine plant IO#12

Positive
Aug 24, 2026

Iofina plc has fully installed an additional brine water source at its IO#11 plant, enabling the facility to draw from two separate brine supplies for greater capacity and resilience. The new feed is expected to boost IO#11’s crystalline iodine...

Other

Iofina CEO Transfers Share Options Following Divorce Decree

Neutral
Aug 12, 2026

Iofina plc reported a change in director share option holdings following a court-mandated transfer involving its Chief Executive Officer. On 11 August 2026, CEO Tom Becker transferred 650,650 existing share options to his former spouse under a Decree...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 17, 2026